Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.

Landy S, Hoagland R, Hoagland NA.

Headache. 2012 Jan;52(1):133-9. doi: 10.1111/j.1526-4610.2011.01992.x. Epub 2011 Aug 29.

PMID:
21883200
2.

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.

Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27.

PMID:
19486178
3.

Sumatriptan and naproxen sodium for the acute treatment of migraine.

Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.

Headache. 2005 Sep;45(8):983-91.

PMID:
16109111
4.

Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.

Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.

Headache. 2012 Apr;52(4):530-43. doi: 10.1111/j.1526-4610.2011.02039.x. Epub 2011 Nov 21.

PMID:
22103635
6.

Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2016 Apr 20;4:CD008541. doi: 10.1002/14651858.CD008541.pub3. Review.

PMID:
27096438
7.

Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.

Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.

Neurology. 2008 Jul 8;71(2):114-21. doi: 10.1212/01.wnl.0000316800.22949.20. Erratum in: Neurology. 2009 Apr 14;72(15):1369.. Toso, Cynthia [added].

PMID:
18606965
8.

Clarification of developing and established clinical allodynia and pain-free outcomes.

Landy SH, McGinnis JE, McDonald SA.

Headache. 2007 Feb;47(2):247-52.

PMID:
17300364
9.

Sumatriptan plus naproxen for acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2013 Oct 21;(10):CD008541. doi: 10.1002/14651858.CD008541.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD008541.

PMID:
24142431
10.

Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.

Smith T, Blumenthal H, Diamond M, Mauskop A, Ames M, McDonald S, Lener S, Burch S.

Headache. 2007 May;47(5):683-92.

PMID:
17501849
11.

Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.

Yang LP.

Drugs. 2013 Aug;73(12):1339-55. doi: 10.1007/s40265-013-0099-y. Review.

PMID:
23912627
12.

Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.

Haberer LJ, Walls CM, Lener SE, Taylor DR, McDonald SA.

Headache. 2010 Mar;50(3):357-73. doi: 10.1111/j.1526-4610.2009.01606.x. Epub 2010 Feb 2.

PMID:
20132340
13.

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial.

Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F.

Headache. 2003 Sep;43(8):835-44.

PMID:
12940804
14.

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.

Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R.

Headache. 2005 Jul-Aug;45(7):850-61.

PMID:
15985101
15.

Naproxen sodium decreases migraine recurrence when administered with sumatriptan.

Krymchantowski AV.

Arq Neuropsiquiatr. 2000 Jun;58(2B):428-30.

16.

Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.

Winner P, Cady RK, Ruoff GE, Frishberg BM, Alexander WJ, Zhang Y, Kori SH, Lener SE.

Mayo Clin Proc. 2007 Jan;82(1):61-8.

PMID:
17285787
17.

SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.

Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.

Headache. 2014 Jan;54(1):67-79. doi: 10.1111/head.12211. Epub 2013 Sep 10.

PMID:
24021029
18.

Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.

Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ.

Curr Med Res Opin. 2011 Nov;27(11):2185-91. doi: 10.1185/03007995.2011.619177. Epub 2011 Sep 26.

PMID:
21942531
20.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Blumenfeld A, Gennings C, Cady R.

Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Review.

PMID:
22221151

Supplemental Content

Support Center